课题基金 / 基金详情

Acquisition of malignant phenotypes in tumour cells mediated by the PD-1/PD-L1 immune checkpoint

Acquisition of malignant phenotypes in tumour cells mediated by the PD-1/PD-L1 immune checkpoint
PD-1/PD-L1免疫检查点介导的肿瘤细胞恶性表型的获得
批准号：
342896
负责人：
Graham Charles H
金额：
$32.3万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2019-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342896&lang=en
关键词：
Cancer Drug Resistance Immune Checkpoint Metastasis

项目摘要

项目成果

Graham Charles H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Important hallmarks of cancer are the ability of tumour cells to evade rejection by the immune system, ability to spread, and resistance to therapy. One way tumour cells avoid immune rejection is by inactivating immune cells through the interaction of spe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of trained immunity in the response to BCG immunotherapy of bladder cancer
Third International Workshop on Nitric Oxide in Cancer Therapy
  • 批准号：
    271293
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.31万
  • 财政年份：
    2012
  • 负责人：
    Graham Charles H
  • 依托单位：
    Queen's University (Kingston, Ontario)
Role of maternal inflammation in the pathophysiology of intrauterine growth restriction and pre-eclampsia
Mechanisms of hypoxia-induced immune escape in cancer and their regulation by nitric oxide
海外基金